RxDoctor Payments Data

Aaron Groth, MD

Family Medicine · Springfield, OHNPI 1508809021

Payments from drug & device makers

$4,576in general payments, 2019–2025

Across 344 payments — averaging $13.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$755
  • Lilly USA, LLC$431
  • Amgen$299
  • Pfizer$268
  • AstraZeneca$150
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$4,562100%
  • Entertainment$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,576 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$125,418
Medicare patients
301
Services billed
2,193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin152$167,576
EliquisApixaban137$123,640
TradjentaLinagliptin102$94,157
OzempicSemaglutide73$89,691
TrulicityDulaglutide80$85,807
Trelegy ElliptaFluticasone/Umeclidin/Vilanter82$72,214
MounjaroTirzepatide42$49,306
JanuviaSitagliptin Phosphate30$44,050
FarxigaDapagliflozin Propanediol30$39,453
Tresiba Flextouch U-200Insulin Degludec22$38,387
LinzessLinaclotide46$36,930
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr43$35,181
XareltoRivaroxaban21$30,403
RybelsusSemaglutide13$28,288
Breo ElliptaFluticasone/Vilanterol47$25,488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$95$275,069268 claims
Lilly USA, LLCTrulicity, Mounjaro$431$135,113122 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$99$132,883172 claims
PfizerEliquis$268$123,640137 claims
Novo NordiskOzempic, Rybelsus$755$117,97886 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$150$53,58258 claims
MerckJanuvia$77$44,05030 claims
AbbVieLinzess, Synthroid$1,077$42,867173 claims
Johnson & JohnsonXarelto$107$30,40321 claims
Astellas Pharma US IncMyrbetriq$133$18,47817 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$38$5,021580 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Springfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →